Literature DB >> 24218450

CD2-associated protein regulates plasmacytoid dendritic cell migration, but is dispensable for their development and cytokine production.

Subhashini Srivatsan1, Melissa Swiecki, Karel Otero, Marina Cella, Andrey S Shaw.   

Abstract

Plasmacytoid dendritic cells (pDCs) are a dendritic cell subset that secrete type I IFNs in response to microbial stimuli. The scaffold protein, CD2-associated protein (CD2AP), is a marker of human pDCs as it is highly expressed in this cell type. Recently, in human pDCs, decreased CD2AP expression appeared to enhance the production of type I IFNs via an inhibitory receptor-induced signaling cascade. In this study, we sought to determine the role of CD2AP in murine pDCs using CD2AP knockout (KO) mice. CD2AP was dispensable for the development of pDCs and for the upregulation of activation markers following stimulation. Loss of CD2AP expression did not affect the production of type I IFNs stimulated by TLR ligation, and only slightly impaired type I IFN production when inhibitory pathways were engaged in vitro. This was also confirmed by showing that CD2AP deficiency did not influence type I IFN production by pDCs in vivo. Because CD2AP plays a role in regulating actin dynamics, we examined the actin cytoskeleton in pDCs and found that activated CD2AP KO pDCs had significantly higher levels of actin polymerization than wild-type pDCs. Using two different inflammation models, we found that CD2AP KO pDCs have a defect in lymph node migration, correlating with the defects in actin dynamics. Our work excludes a role for CD2AP in the regulation of type I IFNs in pDCs, and suggests that the major function of CD2AP is on the actin cytoskeleton, affecting migration to local lymph nodes under conditions of inflammation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24218450      PMCID: PMC3858535          DOI: 10.4049/jimmunol.1300454

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  52 in total

1.  CIN85 regulates the ligand-dependent endocytosis of the IgE receptor: a new molecular mechanism to dampen mast cell function.

Authors:  Rosa Molfetta; Francesca Belleudi; Giovanna Peruzzi; Stefania Morrone; Laura Leone; Ivan Dikic; Mario Piccoli; Luigi Frati; Maria Rosaria Torrisi; Angela Santoni; Rossella Paolini
Journal:  J Immunol       Date:  2005-10-01       Impact factor: 5.422

2.  Structure and function analysis of the CMS/CIN85 protein family identifies actin-bundling properties and heterotypic-complex formation.

Authors:  Gabriel Gaidos; Shefali Soni; Duane J Oswald; Paul A Toselli; Kathrin H Kirsch
Journal:  J Cell Sci       Date:  2007-07-15       Impact factor: 5.285

3.  Differential MHC class II synthesis and ubiquitination confers distinct antigen-presenting properties on conventional and plasmacytoid dendritic cells.

Authors:  Louise J Young; Nicholas S Wilson; Petra Schnorrer; Anna Proietto; Toine ten Broeke; Yohei Matsuki; Adele M Mount; Gabrielle T Belz; Meredith O'Keeffe; Mari Ohmura-Hoshino; Satoshi Ishido; Willem Stoorvogel; William R Heath; Ken Shortman; Jose A Villadangos
Journal:  Nat Immunol       Date:  2008-10-12       Impact factor: 25.606

4.  A novel adaptor protein orchestrates receptor patterning and cytoskeletal polarity in T-cell contacts.

Authors:  M L Dustin; M W Olszowy; A D Holdorf; J Li; S Bromley; N Desai; P Widder; F Rosenberger; P A van der Merwe; P M Allen; A S Shaw
Journal:  Cell       Date:  1998-09-04       Impact factor: 41.582

5.  CD2AP in mouse and human podocytes controls a proteolytic program that regulates cytoskeletal structure and cellular survival.

Authors:  Suma Yaddanapudi; Mehmet M Altintas; Andreas D Kistler; Isabel Fernandez; Clemens C Möller; Changli Wei; Vasil Peev; Jan B Flesche; Anna-Lena Forst; Jing Li; Jaakko Patrakka; Zhijie Xiao; Florian Grahammer; Mario Schiffer; Tobias Lohmüller; Thomas Reinheckel; Changkyu Gu; Tobias B Huber; Wenjun Ju; Markus Bitzer; Maria P Rastaldi; Phillip Ruiz; Karl Tryggvason; Andrey S Shaw; Christian Faul; Sanja Sever; Jochen Reiser
Journal:  J Clin Invest       Date:  2011-09-12       Impact factor: 14.808

6.  Identification of a novel inhibitory actin-capping protein binding motif in CD2-associated protein.

Authors:  Serawit Bruck; Tobias B Huber; Robert J Ingham; Kyoungtae Kim; Hanspeter Niederstrasser; Paul M Allen; Tony Pawson; John A Cooper; Andrey S Shaw
Journal:  J Biol Chem       Date:  2006-05-16       Impact factor: 5.157

Review 7.  Immune functions and recruitment of plasmacytoid dendritic cells in psoriasis.

Authors:  Cristina Albanesi; Claudia Scarponi; Daniela Bosisio; Silvano Sozzani; Giampiero Girolomoni
Journal:  Autoimmunity       Date:  2010-04       Impact factor: 2.815

8.  Novel markers of normal and neoplastic human plasmacytoid dendritic cells.

Authors:  Teresa Marafioti; Jennifer C Paterson; Erica Ballabio; Kaaren K Reichard; Sara Tedoldi; Kevin Hollowood; Michael Dictor; Martin-Leo Hansmann; Stefano A Pileri; Martin J Dyer; Silvano Sozzani; Ivan Dikic; Andrey S Shaw; Tony Petrella; Harald Stein; Peter G Isaacson; Fabio Facchetti; David Y Mason
Journal:  Blood       Date:  2008-01-24       Impact factor: 22.113

Review 9.  Interleukin-12 and the regulation of innate resistance and adaptive immunity.

Authors:  Giorgio Trinchieri
Journal:  Nat Rev Immunol       Date:  2003-02       Impact factor: 53.106

10.  A cell-surface molecule selectively expressed on murine natural interferon-producing cells that blocks secretion of interferon-alpha.

Authors:  Amanda Blasius; William Vermi; Anne Krug; Fabio Facchetti; Marina Cella; Marco Colonna
Journal:  Blood       Date:  2003-12-24       Impact factor: 22.113

View more
  14 in total

Review 1.  Dendritic cell migration in health and disease.

Authors:  Tim Worbs; Swantje I Hammerschmidt; Reinhold Förster
Journal:  Nat Rev Immunol       Date:  2016-11-28       Impact factor: 53.106

2.  Eliminating microglia in Alzheimer's mice prevents neuronal loss without modulating amyloid-β pathology.

Authors:  Elizabeth E Spangenberg; Rafael J Lee; Allison R Najafi; Rachel A Rice; Monica R P Elmore; Mathew Blurton-Jones; Brian L West; Kim N Green
Journal:  Brain       Date:  2016-02-26       Impact factor: 13.501

Review 3.  The multifaceted biology of plasmacytoid dendritic cells.

Authors:  Melissa Swiecki; Marco Colonna
Journal:  Nat Rev Immunol       Date:  2015-07-10       Impact factor: 53.106

4.  Plasmacytoid Dendritic Cells Facilitate Th Cell Cytokine Responses throughout Schistosoma mansoni Infection.

Authors:  Lauren M Webb; Alexander T Phythian-Adams; Alice H Costain; Sheila L Brown; Rachel J Lundie; Josephine Forde-Thomas; Peter C Cook; Lucy H Jackson-Jones; Angela K Marley; Hermelijn H Smits; Karl F Hoffmann; Elia D Tait Wojno; Andrew S MacDonald
Journal:  Immunohorizons       Date:  2021-08-30

5.  Cutting Edge: Critical Role of Glycolysis in Human Plasmacytoid Dendritic Cell Antiviral Responses.

Authors:  Gagan Bajwa; Ralph J DeBerardinis; Baomei Shao; Brian Hall; J David Farrar; Michelle A Gill
Journal:  J Immunol       Date:  2016-01-29       Impact factor: 5.422

6.  Microbiota induces tonic CCL2 systemic levels that control pDC trafficking in steady state.

Authors:  M Swiecki; H L Miller; R Sesti-Costa; M Cella; S Gilfillan; M Colonna
Journal:  Mucosal Immunol       Date:  2016-11-09       Impact factor: 7.313

7.  PAWS1 controls cytoskeletal dynamics and cell migration through association with the SH3 adaptor CD2AP.

Authors:  Timothy D Cummins; Kevin Z L Wu; Polyxeni Bozatzi; Kevin S Dingwell; Thomas J Macartney; Nicola T Wood; Joby Varghese; Robert Gourlay; David G Campbell; Alan Prescott; Eric Griffis; James C Smith; Gopal P Sapkota
Journal:  J Cell Sci       Date:  2018-01-10       Impact factor: 5.235

Review 8.  Microglial Phagocytosis: A Disease-Associated Process Emerging from Alzheimer's Disease Genetics.

Authors:  Anna Podleśny-Drabiniok; Edoardo Marcora; Alison M Goate
Journal:  Trends Neurosci       Date:  2020-10-27       Impact factor: 16.978

9.  Inter-kingdom Signaling by the Legionella Quorum Sensing Molecule LAI-1 Modulates Cell Migration through an IQGAP1-Cdc42-ARHGEF9-Dependent Pathway.

Authors:  Sylvia Simon; Ursula Schell; Natalie Heuer; Dominik Hager; Michael F Albers; Jan Matthias; Felix Fahrnbauer; Dirk Trauner; Ludwig Eichinger; Christian Hedberg; Hubert Hilbi
Journal:  PLoS Pathog       Date:  2015-12-03       Impact factor: 6.823

Review 10.  Cross Talk between Inhibitory Immunoreceptor Tyrosine-Based Activation Motif-Signaling and Toll-Like Receptor Pathways in Macrophages and Dendritic Cells.

Authors:  Ivan Hirsch; Vaclav Janovec; Ruzena Stranska; Nathalie Bendriss-Vermare
Journal:  Front Immunol       Date:  2017-04-07       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.